Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,010,351 papers from all fields of science
Search
Sign In
Create Free Account
Filtering Surgery
Known as:
Surgery, Filtration
, filter surgery
, Surgery, Filtering
Expand
A surgical procedure used in treatment of glaucoma in which an opening is created through which aqueous fluid may pass from the anterior chamber into…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Educational aspects
Glaucoma
Molteno Implants
legislation & jurisprudence
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
Zhongqiu Li
,
T. Van Bergen
,
+8 authors
I. Stalmans
Investigative Ophthalmology and Visual Science
2009
Corpus ID: 16180643
PURPOSE Filtration failure due to excessive postoperative scarring remains a major problem after glaucoma surgery. The authors…
Expand
Highly Cited
2003
Highly Cited
2003
Morphologic Classification of Filtering Blebs after Glaucoma Filtration Surgery: The Indiana Bleb Appearance Grading Scale
L. Cantor
,
A. Mantravadi
,
D. WuDunn
,
Kala Swamynathan
,
A. Cortes
Journal of glaucoma
2003
Corpus ID: 29062631
PurposeTo establish a new classification system for filtering blebs according to clinical morphologic parameters. The purpose of…
Expand
Highly Cited
2003
Highly Cited
2003
Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.
Anna L. Mead
,
Tina T. L. Wong
,
M. Cordeiro
,
Ian K. Anderson
,
P. T. Khaw
Investigative Ophthalmology and Visual Science
2003
Corpus ID: 9966643
PURPOSE Postoperative subconjunctival wound healing remains the commonest cause of late bleb failure after glaucoma filtration…
Expand
Highly Cited
1999
Highly Cited
1999
Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies.
C. Baudouin
,
P. Pisella
,
+4 authors
A. Béchetoille
Ophthalmology (Rochester, Minn.)
1999
Corpus ID: 23982087
Highly Cited
1999
Highly Cited
1999
Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent.
M. F. Cordeiro
,
P. T. Khaw
Investigative Ophthalmology and Visual Science
1999
Corpus ID: 6335692
PURPOSE Currently available anti-scarring regimens for glaucoma filtration surgery have potentially blinding complications and…
Expand
Review
1996
Review
1996
Long-term survival of Molteno glaucoma drainage devices.
Richard P. Mills
,
Adam Reynolds
,
M. Emond
,
William E. Barlow
,
M. M. Leen
Ophthalmology (Rochester, Minn.)
1996
Corpus ID: 26046353
Highly Cited
1994
Highly Cited
1994
Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.
D. Broadway
,
I. Grierson
,
C. O'brien
,
R. Hitchings
1994
Corpus ID: 19112651
Objective: To determine the effect of long-term topical antiglaucoma therapy on the results of glaucoma filtration surgery and to…
Expand
Highly Cited
1992
Highly Cited
1992
Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts.
H. Jampel
Ophthalmology (Rochester, Minn.)
1992
Corpus ID: 24627395
Highly Cited
1988
Highly Cited
1988
Cellular proliferation after experimental glaucoma filtration surgery.
H. Jampel
,
Lorraine J. B. McGuigan
,
G. Dunkelberger
,
Nancy L'Hernault
,
H. Quigley
A M A Archives of Ophthalmology
1988
Corpus ID: 33988563
We used light microscopic autoradiography to determine the time course of cellular incorporation of tritiated thymidine (a…
Expand
Highly Cited
1987
Highly Cited
1987
Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects.
R. Weinreb
Ophthalmology (Rochester, Minn.)
1987
Corpus ID: 41443135
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE